7-130685195-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_052933.4(TSGA13):c.16C>A(p.Gln6Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,461,132 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_052933.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TSGA13 | NM_052933.4 | c.16C>A | p.Gln6Lys | missense_variant | 2/8 | ENST00000356588.8 | |
TSGA13 | NM_001304968.2 | c.16C>A | p.Gln6Lys | missense_variant | 3/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TSGA13 | ENST00000356588.8 | c.16C>A | p.Gln6Lys | missense_variant | 2/8 | 1 | NM_052933.4 | P1 | |
TSGA13 | ENST00000456951.5 | c.16C>A | p.Gln6Lys | missense_variant | 3/9 | 2 | P1 | ||
TSGA13 | ENST00000443954.5 | c.16C>A | p.Gln6Lys | missense_variant | 3/6 | 4 | |||
TSGA13 | ENST00000438346.1 | c.16C>A | p.Gln6Lys | missense_variant | 3/5 | 5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251418Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135874
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461132Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 726696
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 19, 2024 | The c.16C>A (p.Q6K) alteration is located in exon 2 (coding exon 1) of the TSGA13 gene. This alteration results from a C to A substitution at nucleotide position 16, causing the glutamine (Q) at amino acid position 6 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at